Unlocking Opportunities in the Lung Cancer Surgery Equipment Market: 2025-2034 Forecast Report

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Lung Cancer Surgery Equipment Industry Market Size Be by 2025?
The market for lung cancer surgery equipment has seen substantial growth in recent years. The market is projected to expand from $3.49 billion in 2024 to $3.73 billion in 2025, signifying a compound annual growth rate (CAGR) of 6.7%. Factors contributing to the growth during the historic period include an increase in smoking incidents, enhancement in early detection rates, improved survival rates post-surgery, a surge in the uptake of lobectomy procedures, cancer screening initiatives by governments, development in hospital infrastructure, the presence of proficient thoracic surgeons, an increase in open thoracotomy surgeries, scarcity of substitutes to surgical procedures, and financial support for cancer surgeries.

What's the Long-Term Growth Forecast for the Lung Cancer Surgery Equipment Market Size Through 2029?
Strong expansion is projected for the lung cancer surgery equipment market in the upcoming years, with predictions reaching $4.79 billion by 2029, boasting a compound annual growth rate (CAGR) of 6.5%. This growth during the forecast period is attributable to factors like an increase in lung cancer among non-smokers, globally aging population, infiltration of minimally invasive surgical techniques, rising demand for robotic-assisted thoracic surgeries, increased healthcare expenditure, improved recovery rates after surgery, a surge in outpatient thoracic procedures, advantageous regulatory backing, increased awareness induced by lung cancer campaigns, and expanded insurance coverage in burgeoning markets. Key trends anticipated during this forecast period embrace the use of robotic-assisted surgical platforms, integration of artificial intelligence in surgical planning, incorporation of 3D imaging in surgeries, invention of more compact thoracoscopic tools, advanced visualization systems, emergence of remote surgical methods, real-time surgical navigation in operating theatres, deployment of smart staplers and surgical instruments, customized surgical equipment through 3D printing, and the utilization of AI-enabled monitoring systems post-surgery.

View the full report here:
https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

What Are the Key Growth Drivers Fueling the Lung Cancer Surgery Equipment Market Expansion?
The lung cancer surgery equipment market is anticipated to expand due to the increasing incidence of lung cancer. This is a condition where abnormal cells disproportionately proliferate in the lungs, largely attributed to smoking or harmful environmental exposures. The rise in lung cancer cases is primarily due to increased exposure to risk factors like tobacco smoke, air pollution, and work-related carcinogens, in addition to an aging population. Lung cancer surgery equipment facilitates diagnosis, removal of cancerous tissue, and post-operative care through accurate surgical procedures and patient tracking. For example, the Cancer Council, a non-profit organization based in Australia, indicated in February 2025 that an estimated 15,122 individuals were diagnosed with lung cancer in Australia in 2024 at an average age of 72. Lung cancer stands as the fifth most frequently diagnosed cancer in Australia, with about one in 20 Australians expected to receive a diagnosis by the age of 85. Consequently, the escalating incidence of lung cancer is fuelling the expansion of the lung cancer surgery equipment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24594&type=smp

What Are the Key Trends Driving Lung Cancer Surgery Equipment Market Growth?
Key players in the lung cancer surgery equipment market are striving to create devices for use in robotically assisted bronchoscopy. They aim to improve the accuracy and safety of tumor localization and biopsy, increase the accessibility to lung nodules that are hard to reach, and facilitate early and reliable detection of lung cancer. Robotically assisted bronchoscopy applies robotic technology to guide a bronchoscope, a slim, flexible tubing, into the lungs with more precision and control compared to the conventional manual techniques. For instance, in March 2025, Johnson and Johnson, a pharmaceutical company based in the United States, made an announcement regarding their MONARCH QUEST system. This advanced technology for robotic-assisted bronchoscopy has been granted the U.S. FDA 510(k) clearance. This system signifies a new progression in the MONARCH Platform, designed to enhance lung cancer diagnosis through minimally invasive procedures. The system collaborates with the GE HealthCare OEC 3D mobile CBCT Imaging System, enabling real-time, intra-procedural 3D imaging, thus upgrading the accuracy of targeting lung nodules, particularly when they are situated in areas of the lung that are difficult to access.

How Is the Lung Cancer Surgery Equipment Market Segmented?
The lung cancer surgery equipment market covered in this report is segmented -

1) By Product Type: Surgical Instruments, Access Devices, Imaging Equipment, Electrosurgical Devices, Biopsy Devices, Patient Monitoring Equipment
2) By Surgery Type: Lobectomy Surgery, Pneumonectomy Surgery, Wedge Resection, Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery
3) By Application: Diagnosis, Treatment, Aftercare And Rehabilitation
4) By End User: Hospitals, Surgical Clinics, Ambulatory Surgical Centers, Research And Academic Institutes

Subsegments:
1) By Surgical Instruments: Scalpels, Forceps, Retractors, Scissors, Sutures
2) By Access Devices: Trocars, Catheters, Guidewires, Introducers
3) By Imaging Equipment: CT Scanners, MRI Machines, PET Scanners, X-Ray Systems, Ultrasound Devices
4) By Electrosurgical Devices: Electrosurgical Generators, Electrosurgical Probes, Electrosurgical Electrodes, Smoke Evacuation Systems
5) By Biopsy Devices: Needle Biopsy Devices, Core Biopsy Devices, Vacuum-Assisted Biopsy Devices, Endoscopic Biopsy Devices
6) By Patient Monitoring Equipment: Pulse Oximeters, ECG Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24594&type=smp

Which Companies Are Leading the Charge in Lung Cancer Surgery Equipment Market Innovation?
Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc., Boston Scientific Corporation, Zimmer Biomet Inc., Olympus Corporation, Intuitive Surgical Inc., Teleflex Incorporated, KARL STORZ GmbH & Co. KG, Integra LifeSciences Corporation, Elekta AB, Accuray Incorporated, Richard Wolf GmbH, Angiodynamics Inc., B. Braun Melsungen AG, Quantum Surgical SAS, Sontec Instruments Inc., Novadaq Technologies Inc.

Which Regions Are Leading the Global Lung Cancer Surgery Equipment Market in Revenue?
North America was the largest region in the lung cancer surgery equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report to*day:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24594

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.